https://newbiologix.com/old-home-3 https://newbiologix.com/about-us https://newbiologix.com/technology https://newbiologix.com/gene-therapy https://newbiologix.com/news https://newbiologix.com/careers https://newbiologix.com/contact https://newbiologix.com/cell-therapy https://newbiologix.com/ngs https://newbiologix.com/legal-notice https://newbiologix.com/privacy-policy https://newbiologix.com/checkout https://newbiologix.com/paypal-checkout https://newbiologix.com/order-confirmation https://newbiologix.com/ngs-and-optical-mapping-platform https://newbiologix.com/genomic-analytical-platform https://newbiologix.com/nbx-eng-hek293-cell-line https://newbiologix.com/raav-testing-platform https://newbiologix.com/xcell-portfolio https://newbiologix.com https://newbiologix.com/events https://newbiologix.com/posters https://newbiologix.com/team/anna-c-maurer https://newbiologix.com/team/deborah-ley https://newbiologix.com/team/efrain-guzman https://newbiologix.com/team/greg-behar https://newbiologix.com/team/igor-fisch https://newbiologix.com/team/mahendra-rao https://newbiologix.com/team/neil-jones https://newbiologix.com/team/nicolas-mermod https://newbiologix.com/team/sir-greg-winter https://newbiologix.com/team/tatjana-bauecker https://newbiologix.com/team/thierry-schuepbach https://newbiologix.com/news/advancing-aav-manufacturing-quality https://newbiologix.com/news/beyond-setbacks-a-vision-for-scalable-smarter-gene-therapy-manufacturing https://newbiologix.com/news/bio-international-convention https://newbiologix.com/news/bioalps-awards-2023-dr-igor-fisch-and-dr-nicolas-mermod-both-receive-the-bioalps-industry-award https://newbiologix.com/news/ensuring-viral-vector-integrity-from-day-one https://newbiologix.com/news/gene-therapies-dont-have-to-cost-4-million-new-production-platforms-reduce-development-costs-and-risks https://newbiologix.com/news/interview-of-igor-fisch-in-pharmaboardroom https://newbiologix.com/news/newbiologix-abstracts-selected-for-two-poster-presentations-at-european-society-of-gene-cell-therapy-2024-congress https://newbiologix.com/news/newbiologix-announces-publication-of-breakthrough-hek293-cell-line-optimized-for-high-quality-raav-production https://newbiologix.com/news/newbiologix-announces-white-paper-on-improving-the-manufacturing-of-recombinant-adeno-associated-viruses-for-use-in-cell-amp-gene-therapies https://newbiologix.com/news/newbiologix-grand-opening-may-11th-2023 https://newbiologix.com/news/newbiologix-in-the-biopole-review-2023-edition-secrets-of-a-serial-entrepreneur https://newbiologix.com/news/newbiologix-launches-next-generation-sequencing-and-optical-mapping-platform-to-drive-the-next-wave-of-biopharmaceutical-discoveries https://newbiologix.com/news/newbiologix-launches-proprietary-hek293-cell-line-for-the-expression-of-viral-vectors-used-in-gene-therapy https://newbiologix.com/news/newbiologix-launches-with-50m-to-advance-novel-technology-platform-for-the-manufacturing-of-gene-and-cell-therapies https://newbiologix.com/news/newbiologix-launches-xcell-tm-raav-production-and-analytics-platform-to-improve-and-accelerate-gene-therapy-development https://newbiologix.com/news/newbiologix-launches-xcell-tm-to-accelerate-optimize-and-scale-gene-and-cell-therapy-production https://newbiologix.com/news/newbiologix-licenses-florabios-hek293-cell-line-for-the-generation-of-novel-and-proprietary-cell-lines-for-the-stable-expression-of-raavs-used-in-gene-therapy https://newbiologix.com/news/newbiologix-licenses-xcell-eng-hek293-cell-line-to-recipharm-advanced-bio-for-development-and-manufacture-of-adeno-associated-virus-aav-therapeutics https://newbiologix.com/news/newbiologix-presents-new-data-at-asgct-on-the-effective-manufacturing-of-raav-based-therapeutics https://newbiologix.com/news/newbiologix-sponsors-charity-gala-2024-in-san-diego-during-bio-international-convention https://newbiologix.com/news/newbiologixs-new-white-paper-highlights-novel-adaptable-hek293-cell-line-for-commercial-raav-production https://newbiologix.com/news/revolutionizing-gene-therapy-with-igor-fisch-ceo-of-newbiologix https://newbiologix.com/news/rewards-in-the-real-world-sitting-down-with-igor-fisch https://newbiologix.com/news/scaling-platform-delivery-of-gene-therapies-an-interview-with-newbiologixs-ceo-igor-fisch https://newbiologix.com/news/un-nouvel-acteur-de-la-therapie-genique https://newbiologix.com/posters/a-novel-pipeline-for-the-genomic-characterization-of-cell-lines https://newbiologix.com/posters/assessment-of-an-automated-multi-dimensional-digital-pcr-workflow-for-the-rapid-evaluation-of-recombinant-aav-genome-integrity https://newbiologix.com/posters/development-of-a-molecular-toolbox-for-the-assessment-of-gene-transcription-during-recombinant-adeno-associated-virus-production https://newbiologix.com/posters/development-of-a-regulated-packaging-cell-line-for-the-production-of-recombinant-adeno-associated-virus-vectors https://newbiologix.com/posters/generation-and-characterization-of-a-novel-hek293-suspension-cell-line-for-raav-production https://newbiologix.com/posters/optimizing-recombinant-adeno-associated-virus-vector-yield-quality-using-a-multi-output-design-of-experiment-approach-applied-to-a-fully-characterized-hek293-cell-line https://newbiologix.com/posters/redefining-raav-vector-analysis-and-quality-control-with-orthogonal-long-read-sequencing-technologies https://newbiologix.com/posters/scalable-and-flexible-recombinant-adeno-associated-virus-vector-production-using-a-fully-characterized-novel-hek293-suspension-cell-line